The test that in 3 minutes shows you're positive and 13 minutes negative

The American research firm “Abbott Labies” announced that it has won approval to market a diagnostic test for coronarys. The new test can produce results within minutes and can be used at the offices of general doctors, in early care clinics, and in hospitals.

The United States already has more coral cases than any other globe. Hospitals are trying to meet demands to test thousands of people for the deadly virus.

Approval for this new test was granted by the United States Food and Drug Administration (FDA), according to authority given to the law on emergencies.

The company “Abbott” distributed a statement informing that it will start distribution this week of new test completes and will increase production to nearly 50,000 tests per day.

It gets an exact result in a few minutes, instead of hours or days. This enables doctors to look at the patient and quickly intervene to prevent the spread of the other people”, says Gavin Cloherty, head of the research work on infectious diseases at the “company.Abbott Labus”.

According to the lab officials, the test can conclude within five minutes if someone has the COVID-19 virus, and within 13 minutes if someone turns negative.

The test will be managed through system I D NOW of this company.

This is the second test approved by FDA, which can be used directly in doctors' offices and in other community health care facilities to offer patients the result immediately.

Another important tool to combat the spread of this virus is for tests to be located where patients are. The Abbott ID system NOW can quickly deliver results where necessary. So it could be in doctors' offices, in hospitals or other places. It is thus a very mobile platform that produces very reliable results for a very short time. So, now we're talking for minutes, and not hours or days, so that the patient can get the result”, says John R. Hackett, Jr., vice president of the “Abbott labs”.

Last week, The FDA approved a test produced by the firm “Cepheid” that can be used at health care stations. The company “Abbott” received approval to produce in large quantities automated tests that can be used initially in labs. 150 thousand of them will be distributed throughout the United States.

“Abbott” said it plans to produce in total for both of these testing platforms about 5 million tests per month.

The FDA has rushed to approve coronavirus tests urgently. Other tests presented by companies “Roche Holding have been adopted in principle AG” and “Thermo Fisher Scientific Inc”.

Enlarging the test has been associated with an increase in confirmed cases with the COVID-19 virus. (VOA)